What is ClinDatrix?
ClinDatrix operates as a specialized Contract Research Organization (CRO), providing comprehensive support services to the pharmaceutical, biotechnology, and medical device industries. The company distinguishes itself by offering high-performance clinical trial management and quality assurance protocols at a competitive price point. By acting as a critical partner in the drug and device development lifecycle, ClinDatrix facilitates the transition of complex medical innovations from laboratory settings to clinical application. Its market position is defined by a commitment to operational excellence, allowing it to serve a diverse international clientele that requires rigorous adherence to global health standards and efficient project execution.
How much funding has ClinDatrix raised?
ClinDatrix has raised a total of $898K across 4 funding rounds:
Debt
$150K
Debt
$98K
Debt
$150K
Debt
$500K
Debt (2020): $150K with participation from PPP
Debt (2021): $98K led by PPP
Debt (2024): $150K, investors not publicly disclosed
Debt (2024): $500K featuring Northeast Bank
Key Investors in ClinDatrix
Northeast Bank
A financial institution providing commercial banking services and debt financing solutions to support corporate growth and operational stability.
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participating in the funding round to support the strategic expansion of the company's clinical research operations.
What's next for ClinDatrix?
With the recent influx of capital, ClinDatrix is well-positioned to accelerate its enterprise-level growth strategy. The firm is expected to prioritize the expansion of its technological infrastructure and the broadening of its service capabilities to meet the increasing demand for decentralized clinical trials and real-world evidence generation. As the CRO market continues to consolidate, this strategic financing provides the necessary liquidity to pursue operational efficiencies and potential service line diversification. Stakeholders should anticipate a focus on scaling global delivery teams and enhancing data management systems, which are essential for maintaining the company's competitive edge in the high-stakes environment of medical product development.
See full ClinDatrix company page
